Proof wedge
3 group practices in the same segment
Shows that the workflow is not a one-off founder sale.
Revenue path, not valuation theater
A $2M company needs evidence a buyer can underwrite: real monthly recurring revenue, activation, retention, and a repeatable segment. This page is the operating path for practices that might fit that motion. It is not a clinical outcome promise and it does not ask for patient data.
No patient identifiers, charts, messages, recordings, or clinical details belong in the request. Use role names and workflow labels only.
Target MRR
$30k–$45k
This is the objective band that can support a $2M SaaS valuation at roughly 4–6× ARR.
Customer shape
20–30
Small outpatient groups are the fastest realistic path because each account can represent more than a solo-provider subscription.
Proof standard
Activated
Signup alone is not enough. Krasyn has to show the practice reached a first workflow outcome and kept using it.
Proof wedge
Shows that the workflow is not a one-off founder sale.
Repeatable motion
Lets a buyer underwrite onboarding, activation, and retention risk.
$2M company path
Gets Krasyn near the $30k–$45k MRR band that can support a $2M SaaS valuation.
The first review is about fit and workflow shape, not a full migration. Tell us the practice size, the bottleneck, and the system you use today. No patient data.
Request the fit review